You have 9 free searches left this month | for more free features.

TrkA

Showing 26 - 43 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, B-cell, Lymphoma, B-Cell Trial in Cincinnati (Blinatumomab, Pembrolizumab)

Withdrawn
  • Leukemia, B-cell
  • Lymphoma, B-Cell
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 30, 2021

Solid Tumor Trial in United Kingdom, United States (ONO-7579)

Terminated
  • Solid Tumor
  • Lake Success, New York
  • +4 more
Sep 11, 2019

Deep Retinal Capillary Ischemia, Paracentral Acute Middle Maculopathy, Acute Macular Neuroretinopathy Trial in Ankara

Completed
  • Deep Retinal Capillary Ischemia
  • +2 more
  • Electromagnetic stimulation
  • Platelet rich plasma
  • Ankara, Türkiye, Turkey
    Ankara University Biotechnology Institute
Jan 23, 2020

Determine the Incidence of NTRK Fusions. NTRK Study

Unknown status
  • Metastatic Solid Tumors
  • Retrospective cohort
  • Bordeaux, Aquitaine, France
    Institut Bergonié
Jul 3, 2019

Gastrointestinal Stromal Tumors Trial in Seoul, (dovitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Seoul,, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020

ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk

Unknown status
  • B-cell Acute Lymphoblastic Leukemia
    • Haifa, Israel
    • +1 more
    Jan 31, 2019

    Healthy Trial in Allschwil, Leeds (rhNGF 0.5 µg/mL Sentinel, rhNGF 5 µg/mL Sentinel, rhNGF 20 µg/mL Sentinel)

    Completed
    • Healthy
    • rhNGF 0.5 µg/mL Sentinel
    • +10 more
    • Allschwil, Switzerland
    • +1 more
    Jul 30, 2019

    Metastatic Breast Cancer Trial in New York (ixabepilone)

    Completed
    • Metastatic Breast Cancer
    • New York, New York
      Weill Medical College of Cornell University
    May 31, 2018

    Osteoarthritis Trial in Berlin (, GZ389988)

    Completed
    • Osteoarthritis
    • Berlin, Germany
      Investigational Site Number 276001
    Aug 16, 2016

    Transient Receptor Potential Vanilloid One Receptor Expression

    Completed
    • Epigastric Pain
    • +3 more
      • Milwaukee, Wisconsin
        Medical College of Wisconsin
      Oct 21, 2015

      Blood and Tissue Samples From Newly Diagnosed Neuroblastoma

      Completed
      • Neuroblastoma
      • RNA analysis
      • +9 more
      • (no location specified)
      May 17, 2016

      First or Second Recurrence of Glioblastoma Trial in Bonn (Dovitinib)

      Unknown status
      • First or Second Recurrence of Glioblastoma
      • Bonn, Germany
        Department of Neurology and Center of Integrated Oncology, Unive
      Apr 18, 2016

      Chronic Myeloid Leukemia Trial in United States (DCC-2036)

      Completed
      • Chronic Myeloid Leukemia
      • Duarte, California
      • +9 more
      Jul 16, 2014

      Alzheimer, Neurodegenerative Diseases, Cancer Trial in Charleston (Yogic Breathing, Attention Control)

      Completed
      • Alzheimer Disease
      • +2 more
      • Yogic Breathing
      • Attention Control
      • Charleston, South Carolina
        Medical University of South Carolina
      Apr 7, 2014

      Onabotulinumtoxina Intradetrusorial Injections and NGF

      Completed
      • Overactive Detrusor
      • Detrusor Hyperreflexia of Bladder
        • Perugia, Italy
          University of Perugia, Dept. of Urology and Andrology
        Jun 25, 2012

        Coronary Artery Disease Trial in Czech Republic, Slovakia (Rosuvastatin)

        Unknown status
        • Coronary Artery Disease
        • Plzen, Czech Republic
        • +3 more
        Jun 20, 2011

        Chronic Pancreatitis Trial in Aalborg, Nijmegen (Pregabalin, )

        Completed
        • Chronic Pancreatitis
        • Aalborg, Denmark
        • +1 more
        Aug 19, 2010

        The Role of IMP3 Expression in Patients With Neuroblastoma

        Completed
        • Neuroblastoma
          • Taipei, Taiwan
            Wen-Ming Hsu
          May 20, 2010